Clinical trials
Phase 3 Carcinoma, Non-Small-Cell Lung trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2002 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 13 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 6 |
| Samsung Medical Center | 4 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 3 |
| Istituto Nazionale per lo Studio e la Cura dei Tumori | 3 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 3 |
| Zhejiang Cancer Hospital | 3 |
| AstraZeneca | 2 |
| Betta Pharmaceuticals Co., Ltd. | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Guangdong Association of Clinical Trials | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 96 |
| Lung Neoplasms | 19 |
| Brain Neoplasms | 5 |
| Bronchial Neoplasms | 3 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma, Bronchogenic | 2 |
| Lung Diseases | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Thoracic Neoplasms | 2 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.